debrisoquine treatment caused a significant ( p less than 0.01 ) decrease in circulating norepinephrine ( -45 % ) , but did not modify plasma levels of angiotensin ii , renin , aldosterone , or epinephrine or the metabolism of sodium or potassium .
C0028351
norepinephrine
C0014563
epinephrine